Olema Pharmaceuticals, Inc. OLMA on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
Business address:
780 BRANNAN STREET, SAN FRANCISCO, CA, 94103
Phone: (415) 651-3316
780 BRANNAN STREET, SAN FRANCISCO, CA, 94103
Phone: (415) 651-3316
Mailing address:
780 BRANNAN STREET, SAN FRANCISCO, CA, 94103
780 BRANNAN STREET, SAN FRANCISCO, CA, 94103
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Filings:
407 EDGAR filings since August 27, 2018
407 EDGAR filings since August 27, 2018
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- January 6, 2025 - S-3: Registration statement under Securities Act of 1933Open documentClick to Open document FilingOpen filingClick to Open filing
- January 3, 2025 - S-3: Registration statement under Securities Act of 1933Open documentClick to Open document FilingOpen filingClick to Open filing
- December 13, 2024 - 144: Report of proposed sale of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 12, 2024 - D: Notice of Exempt Offering of SecuritiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 11, 2024 - 144: Report of proposed sale of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- December 10, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- December 2, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- November 12, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- September 27, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 7.01 - Regulation FD Disclosure
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- November 12, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 6, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 8, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- March 11, 2024 - 10-K: Annual report for year ending December 31, 2023Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 26, 2024 - DEF 14A: Other definitive proxy statementsOpen documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- December 18, 2024 - 4/A: Statement of changes in beneficial ownership of securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 17, 2024 - 4: Statement of changes in beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 17, 2024 - 4: Statement of changes in beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- December 11, 2024 - SC 13G: Statement of Beneficial Ownership by Certain InvestorsOpen documentClick to Open document FilingOpen filingClick to Open filing
- December 4, 2024 - SC 13D/A: General Statement of Acquisition of Beneficial Ownership - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of Beneficial Ownership by Certain Investors - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
Form type | Form description | Filing date | Reporting date |
---|
0
Showing 1 to 407 of 407 entries
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors